Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients
Victoria Ros‐Castelló(Universidad de Alcalá), Jaime Masjuán(Universidad de Alcalá), Juan Luis Chico‐García(Universidad de Alcalá), Rocío Vera-Lechuga(Universidad de Alcalá), Antonio Culebras(Hospital Universitario Ramón y Cajal), Consuelo Matute-Lozano(Universidad de Alcalá), Arantxa Sánchez‐Sánchez(Universidad de Alcalá), Ana Gómez‐López(Hospital Universitario Ramón y Cajal), Araceli Alonso‐Cánovas(Universidad de Alcalá), Elena Natera‐Villalba(Universidad de Alcalá), Sebastián García‐Madrona(Instituto Ramón y Cajal de Investigación Sanitaria), Alicia de Felipe Mimbrera(Universidad de Alcalá)
Cited by 20
Related Papers
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
|Nature Communications|2021|345